Long-Term Outcome of Eyes with Vitrectomy for Submacular and/or Vitreous Hemorrhage in Neovascular Age-Related Macular Degeneration

Table 1

Baseline characteristics of the patients.

Characteristics	SMH	VH
Number of patients/eyes	8/8	17/17
Gender ratio: male/female	4/4	12/5
Average age, years	73.8 ± 13.2 (48–89)	77.3 ± 7.1 (67–89)
Lens status: phakic/IOL	7/1	11/6
Subtype of nAMD, number of eyes
PCV/RAP/tAMD	7/0/1	11/2/4
PCV/non-PCV	7/1	11/6
Mean greatest diameter of SMH, DD	4.0 ± 1.6 (2.0–6.7)
Mean BCVA, logMAR (range in decimal)	0.96 ± 0.65 (0.01–0.7)	1.82 ± 0.67 (LP (+)−0.6)
Mean time from onset to initial PPV, days	9.3 ± 4.6 (4–17)	45.9 ± 40.0 (13–142) excluding 4 eyes with unknown duration

Data are expressed as number of patients/eyes or mean ± standard deviation. SMH: submacular hemorrhage, VH: vitreous hemorrhage, IOL: intraocular lens, CNV: choroidal neovascularization, PCV: polypoidal choroidal vasculopathy, RAP: retinal angiomatous proliferation, tAMD: typical age-related macular degeneration, DD: disc diameter, BCVA: best-corrected visual acuity, LP: light perception, PPV: pars plana vitrectomy.